 |
 |

Potential Time Course of Human Immunodeficiency Virus Type 1Associated Minor Motor Deficits
Electrophysiologic and Positron Emission Tomography Findings
Hans-Jürgen von Giesen, MD;
Christina Antke, MD;
Harald Hefter, MD, PhD;
Frank Wenserski, MD;
Rüdiger J. Seitz, MD;
Gabriele Arendt, MD
Arch Neurol. 2000;57:1601-1607.
Background We tested whether metabolic abnormalities in the prefrontal-striatal circuitry as demonstrated by positron emission tomography (PET) were present in patients seropositive for human immunodeficiency virus type 1 (HIV-1) with HIV-1associated minor motor deficits as demonstrated by quantitative motor testing.
Patients We examined 19 HIV-1positive patients, covering the range from normal results of quantitative motor testing to clearly pathologic psychomotor slowing indicative of HIV-1associated minor motor deficits. None fulfilled the clinical criteria for HIV-1associated dementia. Results were compared with those of 15 healthy volunteers.
Methods All subjects underwent clinical examination, routine magnetic resonance (MR) imaging, and electrophysiologic motor testing at the time of PET.
Results Seven HIV-1positive patients showed significant hypermetabolism in the basal ganglia. Nine patients showed a significant frontomesial hypometabolism.
Conclusions The data of our cross-sectional study strongly suggest a characteristic time course in the development of HIV-1associated minor motor deficits. Hypermetabolism in the basal ganglia is associated initially with normal motor performance. Moderate motor slowing appears at a later stage when basal ganglia hypermetabolism drops toward hypometabolism. More severe functional deficits and highly pathologic motor slowing become manifest when hypometabolism is most widespread in the basal ganglia. This stage leads to dementia.
From the Departments of Neurology (Drs von Giesen, Antke, Hefter, Seitz, and Arendt) and Diagnostic Radiology (Dr Wenserski), Heinrich-Heine-University, Düsseldorf, Germany.
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Biomarkers of HIV-1 CNS infection and injury
Price et al.
Neurology 2007;69:1781-1788.
ABSTRACT
| FULL TEXT
Putamen Hypertrophy in Nondemented Patients With Human Immunodeficiency Virus Infection and Cognitive Compromise
Castelo et al.
Arch Neurol 2007;64:1275-1280.
ABSTRACT
| FULL TEXT
Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients
Ances et al.
Neurology 2006;66:862-866.
ABSTRACT
| FULL TEXT
HIV Dementia Scale and Psychomotor Slowing--The Best Methods in Screening for Neuro-AIDS
von Giesen et al.
J. Neuropsychiatry Clin. Neurosi. 2005;17:185-191.
ABSTRACT
| FULL TEXT
Human Immmunodeficiency Virus 1-associated Minor Motor Disorders: Perfusion-weighted MR Imaging and H MR Spectroscopy
Wenserski et al.
Radiology 2003;228:185-192.
ABSTRACT
| FULL TEXT
Basal Ganglia Metabolite Abnormalities in Minor Motor Disorders Associated With Human Immunodeficiency Virus Type 1
von Giesen et al.
Arch Neurol 2001;58:1281-1286.
ABSTRACT
| FULL TEXT
|